Head to Head Survey: Tyra Biosciences (NASDAQ:TYRA) & Wellness Center USA (OTCMKTS:WCUI)

Tyra Biosciences (NASDAQ:TYRA) and Wellness Center USA (OTCMKTS:WCUI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability and risk.

Volatility and Risk

Tyra Biosciences has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Wellness Center USA has a beta of 1.67, meaning that its share price is 67% more volatile than the S&P 500.

Profitability

This table compares Tyra Biosciences and Wellness Center USA’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tyra Biosciences	N/A	-24.56%	-23.31%
Wellness Center USA	N/A	N/A	N/A

Earnings & Valuation

This table compares Tyra Biosciences and Wellness Center USA”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tyra Biosciences	N/A	N/A	-$69.13 million	($1.61)	-9.55
Wellness Center USA	$660,000.00	0.08	-$750,000.00	N/A	N/A

Wellness Center USA has higher revenue and earnings than Tyra Biosciences.

Analyst Ratings

This is a breakdown of recent recommendations for Tyra Biosciences and Wellness Center USA, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tyra Biosciences	0	0	5	0	3.00
Wellness Center USA	0	0	0	0	0.00

Tyra Biosciences presently has a consensus price target of $31.00, suggesting a potential upside of 101.69%. Given Tyra Biosciences’ stronger consensus rating and higher probable upside, equities research analysts clearly believe Tyra Biosciences is more favorable than Wellness Center USA.

Institutional & Insider Ownership

84.1% of Tyra Biosciences shares are held by institutional investors. Comparatively, 0.0% of Wellness Center USA shares are held by institutional investors. 15.4% of Tyra Biosciences shares are held by company insiders. Comparatively, 15.7% of Wellness Center USA shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Wellness Center USA beats Tyra Biosciences on 6 of the 10 factors compared between the two stocks.

About Tyra Biosciences

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

About Wellness Center USA

Wellness Center USA, Inc. engages in the healthcare and medical business in the United States and internationally. The company operates through Medical Devices; and Authentication and Encryption Products and Services segments. It is primarily involved in the marketing and distribution of online sports and nutrition supplements. The company also designs, develops, manufactures, markets, and distributes targeted ultraviolet phototherapy devices that include Psoria-Light, which is used in targeted PUVA photochemistry and UVB phototherapy for the treatment of skin conditions, such as psoriasis, vitiligo, atopic dermatitis, seborrheic dermatitis, and leukoderma. In addition, it offers intelligent microparticles, which provide technologies within the security and supply chain management vertical sectors; and ActiveDuty, a data intelligence service comprising proprietary, unprecedented, and actionable technology, which include a suite of analytical tools, such as artificial intelligence and social psychology for industries, companies, and agencies. The company was incorporated in 2010 and is based in Tucson, Arizona.